In contrast to BPH, most prostate carcinomas contain p27 mRNA but low to undetectable levels of p27Kip1 protein, suggesting post-transcriptional alterations in the gene's activity [6,7]. The gene discussed is CDKN1B; the disease is benign prostatic hyperplasia.